AbbVie affirms FY2026 adjusted EPS guidance at $13.87-$14.07
AbbVie affirms FY2026 adjusted EPS guidance of $13.87-$14.07 versus a $14.08 analyst estimate.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AbbVie affirms FY2026 adjusted EPS guidance of $13.87-$14.07 versus a $14.08 analyst estimate.